Search

Search Results
Results 26031 - 26040 of 26164 for AIDS
  • Actemra PFP AI
    Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Actemra PFP AI intended for persons living in Australia.
  • Entresto
    Drug - 6 Dec 2022
    Consumer Medicine Information (CMI) about Entresto intended for persons living in Australia.
  • Actemra PFS
    Drug - 24 Nov 2022
    Consumer Medicine Information (CMI) about Actemra PFS intended for persons living in Australia.
  • Xalkori
    Drug - 8 Nov 2022
    Consumer Medicine Information (CMI) about Xalkori intended for persons living in Australia.
  • Caverject Impulse
    Drug - 7 Oct 2022
    Consumer Medicine Information (CMI) about Caverject Impulse intended for persons living in Australia.
  • Rixadone
    Drug - 8 Sep 2022
    Consumer Medicine Information (CMI) about Rixadone (risperidone) intended for persons living in Australia.
  • Actemra
    Drug - 5 Sep 2022
    Consumer Medicine Information (CMI) about Actemra intended for persons living in Australia.
  • Interleukin-4 receptor (IL-4R): A drug target with massive potential
    White Paper - 30 Aug 2022
    The interleukin-4 receptor (IL-4R) is emerging as a potential drug target, projected to potentially be worth up to 10 billion USD. In this article, ACROBiosystems discusses why it is such an...
  • VEGF: A consistent target for antitumor therapy
    White Paper - 30 Aug 2022
    In this article, ACROBiosystems discusses Vascular Endothelial Growth Factor (VEGF) and its enduring use as a target in antitumor therapy.
  • Glivec Tablets
    Drug - 3 Aug 2022
    Consumer Medicine Information (CMI) about Glivec Tablets intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback